Pat Rayman
Impact in
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Immunology top 10%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 10
- Cancer Immunotherapy and Biomarkers 8
- Inflammatory Biomarkers in Disease Prognosis 2
- Cancer Cells and Metastasis 2
- Immunology 10
- Immune cells in cancer 6
- Immune Cell Function and Interaction 3
- Inflammation biomarkers and pathways 2
- Immunotherapy and Immune Responses 2
- Co-authors
- James H. Finke (10 shared papers)Jennifer S. Ko (2 shared papers)Peter A. Cohen (2 shared papers)Brian I. Rini (5 shared papers)Joanna Ireland (2 shared papers)J. H. Finke (2 shared papers)Daniel J. Lindner (2 shared papers)Denise A. Hatala (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)The Journal of Immunology (1 paper)Frontiers in Oncology (1 paper)Photodiagnosis and Photodynamic Therapy (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Pat Rayman
15 papers receiving 578 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 193
- Immunology 253
- Oncology 249
- Pulmonary and Respiratory Medicine 116
- Molecular Biology 192
Countries citing papers authored by Pat Rayman
This map shows the geographic impact of Pat Rayman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pat Rayman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pat Rayman more than expected).
Fields of papers citing papers by Pat Rayman
This network shows the impact of papers produced by Pat Rayman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pat Rayman. The network helps show where Pat Rayman may publish in the future.
Co-authors
The 25 scholars most cited alongside Pat Rayman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 226 | |
| 2 | 2013 | 198 | |
| 3 | 2013 | 41 | |
| 4 | 2022 | 30 | |
| 5 | 2012 | 29 | |
| 6 | The Bcl-2 transgene protects T cells from renal cell carcinoma-mediated apoptosis. | 2003 | 15 |
| 7 | 1995 | 14 | |
| 8 | 2024 | 8 | |
| 9 | 2021 | 6 | |
| 10 | 2022 | 4 | |
| 11 | 2016 | 4 | |
| 12 | 2024 | 4 | |
| 13 | 2010 | 2 | |
| 14 | 2010 | 1 | |
| 15 | 2013 | 1 | |
| 16 | 2024 | 0 |
About Pat Rayman
Pat Rayman is a scholar working on Oncology, Immunology, Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 583 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Immune cells in cancer (6 papers), Immune Cell Function and Interaction (3 papers), Cancer Genomics and Diagnostics (2 papers), Inflammation biomarkers and pathways (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Immunotherapy and Immune Responses (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (193 citations), Immunology (253 citations), Oncology (249 citations), Pulmonary and Respiratory Medicine (116 citations) and Molecular Biology (192 citations). Pat Rayman has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include James H. Finke, Jennifer S. Ko, Peter A. Cohen, Brian I. Rini, Joanna Ireland, J. H. Finke, Daniel J. Lindner, Denise A. Hatala, Maryam Zamanian-Daryoush and Jonathan D. Smith. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology, Frontiers in Oncology, Photodiagnosis and Photodynamic Therapy and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.